Anzeige
Mehr »
Login
Donnerstag, 09.12.2021 Börsentäglich über 12.000 News von 671 internationalen Medien
Ja ist denn heut schon Weihnachten? 822%-Rakete zündet die Triebwerke!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
22.09.Amgen to collab with Verastem on KRAS combination treatment
22.09.CHMP recommends Nucala for three new indications
22.09.New UK partnership aims to help build startup companies focused on cancer
22.09.Government review highlights the impact of overprescribing medicines
21.09.FDA approves Exelixis' Cabometyx for differentiated thyroid cancer
21.09.NHS patients gain access to COVID-19 treatment Ronapreve
21.09.Mirati's adagrasib scores encouraging results in KRAS-mutated lung cancer
21.09.Positive topline results for Pfizer/BioNTech jab in five to 11-year-olds
20.09.Sanofi/Regeneron's Libtayo hits the mark in first-line NSCLC
20.09.Promising early results for new ovarian cancer drug combo
20.09.Enhertu reduces breast cancer disease progression or death by 72%
17.09.2021 PM Society Digital Awards winners announced
17.09.Novartis says its radioligand therapy boosts health-related quality of life
17.09.Keytruda made available on the NHS for certain oesophageal cancer patients
17.09.Novavax joins Oxford mix-and-match COVID-19 vaccine study in adolescents
16.09.Moderna to collaborate with AbCellera
16.09.Pfizer UK, Entia partner on home blood monitoring device for breast cancer patients
16.09.BioCryst's HAE med Orladeyo wins NICE nod
16.09.New research programme aims to combat medulloblastoma
15.09.Research identifies possible link between antibiotic use and breast cancer growth
15.09.New patient coalition for digital tech in health launches
15.09.NICE backs Opdivo for head and neck cancer
14.09.Within3 launches new insights management platform
14.09.First patient receives low-dose psilocybin in rare headache disorder trial
14.09.SMC OKs three new meds in latest decisions